These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7738778)

  • 1. [Inhibitory effects of sepimostat mesilate (FUT-187) on the activities of trypsin-like serine proteases in vitro].
    Nakamura K; Johmura A; Oda M; Ino Y; Uchiyama H; Ohtani H; Miyazaki H; Kurumi M; Akizawa Y; Oka T
    Yakugaku Zasshi; 1995 Mar; 115(3):201-12. PubMed ID: 7738778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments.
    Aoyama T; Ino Y; Ozeki M; Oda M; Sato T; Koshiyama Y; Suzuki S; Fujita M
    Jpn J Pharmacol; 1984 Jul; 35(3):203-27. PubMed ID: 6482087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological studies on 6-amidino-2-naphthyl[4-(4,5-dihydro-1H-imidazol-2-yl)amino] benzoate dimethane sulfonate (FUT-187). I: Inhibitory activities on various kinds of enzymes in vitro and anticomplement activity in vivo.
    Oda M; Ino Y; Nakamura K; Kuramoto S; Shimamura K; Iwaki M; Fujii S
    Jpn J Pharmacol; 1990 Jan; 52(1):23-34. PubMed ID: 1689782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of newly synthesized active center-directed trypsin-like serine protease inhibitors on the complement system.
    Ueda N; Midorikawa A; Ino Y; Oda M; Nakamura K; Suzuki S; Kurumi M
    Inflamm Res; 2000 Jan; 49(1):42-6. PubMed ID: 10778920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo effects of camostat mesilate on plasma kallikrein, plasma kininase II and renal kallikrein of man.
    Bönner G; Babst H; Kaufmann W
    Arzneimittelforschung; 1987 May; 37(5):535-7. PubMed ID: 3040018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of ONO-3307 on various proteases and tissue thromboplastin in vitro and on experimental thrombosis in vivo.
    Matsuoka S; Futagami M; Ohno H; Imaki K; Okegawa T; Kawasaki A
    Jpn J Pharmacol; 1989 Dec; 51(4):455-63. PubMed ID: 2515329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sepimostat mesilate on experimental venous thrombosis in rats.
    Tsuruda A; Kanno S; Ohtani H; Suzuki R; Nishioka M; Koshiyama Y; Kurumi M
    Thromb Res; 2001 Feb; 101(3):193-201. PubMed ID: 11228342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Camostat mesilate inhibits prostasin activity and reduces blood pressure and renal injury in salt-sensitive hypertension.
    Maekawa A; Kakizoe Y; Miyoshi T; Wakida N; Ko T; Shiraishi N; Adachi M; Tomita K; Kitamura K
    J Hypertens; 2009 Jan; 27(1):181-9. PubMed ID: 19145783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of a new synthetic protease inhibitor (FUT-175) on the coagulation system.
    Hitomi Y; Ikari N; Fujii S
    Haemostasis; 1985; 15(3):164-8. PubMed ID: 3161808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral administration of sepimostat mesilate prevents acute alcohol pancreatic injury in rats.
    Yuasa C; Irimura K; Oda M; Fukui K; Oka T
    J Pharm Pharmacol; 1999 Jul; 51(7):867-71. PubMed ID: 10467964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological studies of FUT-175, nafamstat mesilate. III. Anti-inflammatory activities of FUT-175].
    Iwaki M; Oda M; Ozeki M; Ino Y; Suzuki K; Koshiyama Y; Motoyoshi A; Ogihara M; Suzuki S; Fujita M
    Nihon Yakurigaku Zasshi; 1984 Oct; 84(4):373-84. PubMed ID: 6239813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative studies of nafamostat mesilate and various serine protease inhibitors in vitro].
    Ino Y; Suzuki K; Sato T; Iwaki M
    Nihon Yakurigaku Zasshi; 1986 Dec; 88(6):449-55. PubMed ID: 2435641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effects of FUT-175 (nafamostat mesilate) on blood coagulation and experimental disseminated intravascular coagulation (DIC)].
    Koshiyama Y; Kobori A; Ogihara M; Yokomoto Y; Ohtani K; Shimamura K; Iwaki M
    Nihon Yakurigaku Zasshi; 1987 Dec; 90(6):313-20. PubMed ID: 3443413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells.
    Yamaya M; Shimotai Y; Hatachi Y; Lusamba Kalonji N; Tando Y; Kitajima Y; Matsuo K; Kubo H; Nagatomi R; Hongo S; Homma M; Nishimura H
    Pulm Pharmacol Ther; 2015 Aug; 33():66-74. PubMed ID: 26166259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of serine proteases of the blood coagulation system by squash family protease inhibitors.
    Hayashi K; Takehisa T; Hamato N; Takano R; Hara S; Miyata T; Kato H
    J Biochem; 1994 Nov; 116(5):1013-18. PubMed ID: 7896727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of various immunological reactions in vivo by a new synthetic complement inhibitor.
    Hitomi Y; Fujii S
    Int Arch Allergy Appl Immunol; 1982; 69(3):262-7. PubMed ID: 6215361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic and pancreatic metabolism and biliary excretion of the protease inhibitor camostat mesilate.
    Beckh K; Weidenbach H; Weidenbach F; Müller R; Adler G
    Int J Pancreatol; 1991; 10(3-4):197-205. PubMed ID: 1787334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of ulcerative colitis with camostat mesilate, a serine protease inhibitor.
    Senda S; Fujiyama Y; Bamba T; Hosoda S
    Intern Med; 1993 Apr; 32(4):350-4. PubMed ID: 8358131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism-based isocoumarin inhibitors for trypsin and blood coagulation serine proteases: new anticoagulants.
    Kam CM; Fujikawa K; Powers JC
    Biochemistry; 1988 Apr; 27(7):2547-57. PubMed ID: 3164217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synthesis of arginylfluoroalkanes, their inhibition of trypsin and blood-coagulation serine proteinases and their anticoagulant activity.
    Ueda T; Kam CM; Powers JC
    Biochem J; 1990 Jan; 265(2):539-45. PubMed ID: 2302184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.